1. Home
  2. RIO vs SNY Comparison

RIO vs SNY Comparison

Compare RIO & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rio Tinto Plc

RIO

Rio Tinto Plc

HOLD

Current Price

$93.16

Market Cap

168.0B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

BUY

Current Price

$40.05

Market Cap

95.7B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
RIO
SNY
Founded
1873
1994
Country
United Kingdom
France
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.0B
95.7B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
RIO
SNY
Price
$93.16
$40.05
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
★ $103.71
$53.72
AVG Volume (30 Days)
1.5M
★ 2.5M
Earning Date
07-29-2026
10-30-2026
Dividend Yield
★ 4.81%
4.46%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.74
$2.06
Revenue Next Year
$2.80
$6.24
P/E Ratio
$15.76
★ $6.14
Revenue Growth
N/A
N/A
52 Week Low
$65.35
$39.18
52 Week High
$112.58
$52.68

Technical Indicators

Market Signals
Indicator
RIO
SNY
Relative Strength Index (RSI) 37.80 33.48
Support Level $87.67 N/A
Resistance Level $94.01 $45.22
Average True Range (ATR) 1.42 0.56
MACD -0.17 -0.18
Stochastic Oscillator 22.12 22.10

Price Performance

Historical Comparison
RIO
SNY

About RIO Rio Tinto Plc

Rio Tinto is a global diversified miner. Iron ore is its major commodity, with lesser contributions from copper and aluminum. Lithium, diamonds, gold, and industrial minerals are more minor contributors. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: